Home/Filings/4/0001127602-25-005755
4//SEC Filing

Strange Kevin T 4

Accession 0001127602-25-005755

CIK 0001531048other

Filed

Feb 18, 7:00 PM ET

Accepted

Feb 19, 8:19 PM ET

Size

10.4 KB

Accession

0001127602-25-005755

Insider Transaction Report

Form 4
Period: 2025-02-19
Strange Kevin T
Chief Financial Officer
Transactions
  • Disposition from Tender

    Common Stock

    2025-02-1967,5020 total
  • Disposition to Issuer

    Stock Option

    2025-02-1911,7610 total
    Exercise: $56.00Common Stock (11,761 underlying)
  • Disposition to Issuer

    Stock Option

    2025-02-195,2930 total
    Exercise: $58.44Common Stock (5,293 underlying)
Footnotes (3)
  • [F1]Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated January 6, 2025, by and among Stryker Corporation ("Parent"), Eagle 1 Merger Sub, Inc. ("Merger Sub"), and Inari Medical, Inc. ("Issuer") on February 19, 2025 (the "Effective Time"), Merger Sub merged with and into Issuer, with Issuer surviving as a wholly owned subsidiary of Parent upon consummation of the transactions contemplated by the Merger Agreement. At the Effective Time, each outstanding share of common stock of the Issuer ("Common Stock") was cancelled and converted into the right to receive $80.00 in cash (the "Merger Consideration"), without interest.
  • [F2]Includes 50,246 restricted stock units ("RSUs"). At the Effective Time, each outstanding award of RSUs was canceled and converted into the right to receive an amount in cash equal to the product of the aggregate number of shares of Common Stock underlying such RSU immediately prior to the Effective Time, multiplied by the Merger Consideration.
  • [F3]At the Effective Time, each outstanding option, whether vested or unvested, was cancelled and converted into the right to receive an amount of cash equal to the product of (i) the aggregate number of shares of Common Stock underlying such option immediately prior to the Effective Time, multiplied by (ii) the amount, if any, by which the Merger Consideration exceeds the exercise price per share of such option, subject to any applicable withholding taxes and in accordance with the terms of the Merger Agreement.

Issuer

Inari Medical, Inc.

CIK 0001531048

Entity typeother

Related Parties

1
  • filerCIK 0002039295

Filing Metadata

Form type
4
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 8:19 PM ET
Size
10.4 KB